Universal Ibogaine Inc. (IBOGF)
OTCMKTS
· Delayed Price · Currency is USD
0.0178
+0.0009 (5.03%)
Apr 25, 2025, 11:00 AM EDT
Universal Ibogaine Market Cap
Universal Ibogaine has a market cap or net worth of $4.44 million as of April 25, 2025. Its market cap has increased by 205.99% in one year.
Market Cap
4.44M
Enterprise Value
6.12M
Revenue
1.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since October 5, 2021, Universal Ibogaine's market cap has decreased from 27.27M to 4.44M, a decrease of -83.70%. That is a compound annual growth rate of -39.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 4.44M | 314.42% |
| Dec 31, 2024 | 1.07M | 47.59% |
| Dec 28, 2023 | 726.62K | -65.76% |
| Dec 30, 2022 | 2.12M | -88.73% |
| Dec 31, 2021 | 18.82M | -30.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SS Innovations International | 1.74B |
| Endo Inc. | 1.64B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 704.15M |
| Elite Pharmaceuticals | 436.82M |
| Northwest Biotherapeutics | 402.62M |
| Glass House Brands | 384.26M |
| CytoDyn | 264.36M |